{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T14:05:14Z","timestamp":1756994714228},"reference-count":0,"publisher":"American Diabetes Association","issue":"10","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[1966,10,1]]},"abstract":"<jats:p>(a) From 67 to 87 per cent of the abnormal triamcinolone glucose tolerance curves are improved after treatment with small doses of hypoglycemic drugs.<\/jats:p>\n               <jats:p>(b) As the weight reducing diet normalized only 6.6 per cent of the abnormal triamcinolone curves, it is possible to conclude that weight reduction alone is not enough to normalize this test.<\/jats:p>\n               <jats:p>(c) The incidence of obstetrical complications (macrosomias, miscarriages, stillbirths, habitual abortion, and congenital malformations) in women with an abnormal triamcinolone test decreases remarkably or disappears after normalization of this test.<\/jats:p>","DOI":"10.2337\/diab.15.10.726","type":"journal-article","created":{"date-parts":[[2014,12,11]],"date-time":"2014-12-11T05:37:01Z","timestamp":1418276221000},"page":"726-729","update-policy":"http:\/\/dx.doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":7,"title":["Modification of Response to the Triamcinolone Glucose Tolerance Test by Treatment with Oral Hypoglycemic Agents Victoriano"],"prefix":"10.2337","volume":"15","author":[{"given":"Victoriano N","family":"Navarrete","sequence":"first","affiliation":[{"name":"Internal Medicine Department, Hospital de Gineco-Obstetricia No. 1, \u201cI.M.S.S.,\u201d\u2008Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel H","family":"Torres","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Hospital de Gineco-Obstetricia No. 1, \u201cI.M.S.S.,\u201d\u2008Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Castelazo","family":"Ayala","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Hospital de Gineco-Obstetricia No. 1, \u201cI.M.S.S.,\u201d\u2008Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos R","family":"Alger","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Hospital de Gineco-Obstetricia No. 1, \u201cI.M.S.S.,\u201d\u2008Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Homero V","family":"Flores","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Hospital de Gineco-Obstetricia No. 1, \u201cI.M.S.S.,\u201d\u2008Mexico City, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/15\/10\/726\/340746\/15-10-726.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/15\/10\/726\/340746\/15-10-726.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:11:05Z","timestamp":1667405465000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/15\/10\/726\/2336\/Modification-of-Response-to-the-Triamcinolone"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1966,10,1]]},"references-count":0,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1966,10,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diab.15.10.726","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1966,10,1]]}}}